Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Please be aware that this might heavily reduce the functionality and appearance of our site
NICE Technology Appraisal TA875 (2023) recommends semaglutide 2.4 mg (Wegovy) for use in adults with obesity or overweight with at least one weight-related comorbidity, when used alongside a reduced-calorie diet and increased physical activity
It is an unapproved investigational compound that did not complete clinical development, has not been authorized by Health Canada for any human or veterinary indication, and is not intended to diagnose, treat, cure, or prevent any disease
References Alhazza, I
Antioxidants 11 , 1342 (2022)
US$ 27.75
US$ 24.06
US$ 25.43
US$ 24.16
US$ 21.90
US$ 28.72
US$ 20.53
US$ 28.58
US$ 29.91
US$ 21.96
